Basic information Safety Supplier Related

1-(BETA-D-2-DEOXYRIBOFURANOSYL)-5-NITROINDOLE

Basic information Safety Supplier Related

1-(BETA-D-2-DEOXYRIBOFURANOSYL)-5-NITROINDOLE Basic information

Product Name:
1-(BETA-D-2-DEOXYRIBOFURANOSYL)-5-NITROINDOLE
Synonyms:
  • 1-(BETA-D-2-DEOXYRIBOFURANOSYL)-5-NITROINDOLE
  • 1-(2-Deoxy-b-D-ribofuranosyl)-5-nitroindole
  • 5-Nitroindole 2'-deoxyribonucleoside
  • 1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-5-nitro-1H-indole
  • 1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole
  • 2'-DEOXY-NITRO INDOLE NUCLEOSIDE
  • 1-(b-D-2-Deoxyribofuranosyl)-5-nitroindole
  • 5-NIdR
CAS:
191421-10-0
MF:
C13H14N2O5
MW:
278.26
Mol File:
191421-10-0.mol
More
Less

1-(BETA-D-2-DEOXYRIBOFURANOSYL)-5-NITROINDOLE Chemical Properties

Boiling point:
572.5±50.0 °C(Predicted)
Density 
1.60±0.1 g/cm3(Predicted)
storage temp. 
-10 to -25°C
solubility 
DMSO: 2mg/mL, clear
form 
Solid
pka
14.01±0.60(Predicted)
color 
Light yellow to yellow
More
Less

1-(BETA-D-2-DEOXYRIBOFURANOSYL)-5-NITROINDOLE Usage And Synthesis

Uses

5-NIdR (1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole), an artificial nucleoside, exhibits the ability to inhibit the replication of DNA lesions generated by Temozolomide (HY-17364). 5-NIdR induces cancer cells apoptosis and arrests cell cycle at G0 phase. 5-NIdR enhances Temozolomide anti-tumor efficacy in murine glioblastoma model[1].

in vivo

5-NIdR (100 mg/kg; ip; for 5 consecutive days), together with Temozolomide (40 mg/kg), results complete tumor regression in a murine xenograft model of glioblastoma. Temozolomide alone only delayed tumor growth[1].

References

[1] Choi JS, et al. Inhibition of Translesion DNA Synthesis as a Novel Therapeutic Strategy to Treat Brain Cancer. Cancer Res. 2018 Feb 15;78(4):1083-1096. DOI:10.1158/0008-5472.CAN-17-2464

1-(BETA-D-2-DEOXYRIBOFURANOSYL)-5-NITROINDOLESupplier

Bide Pharmatech Ltd.
Tel
400-164-7117 13681763483
Email
product02@bidepharm.com
Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Email
info@efebio.com
Shenzhen Regent Biochemical Technology Co., Ltd.
Tel
0755-85201366 18938635012
Email
sales@regentsciences.com
Zhengzhou Granlen Sciences, ltd.
Tel
0371-85513397 +86-18610099868
Email
info@granlen.com
NewCan Biotech Limited
Tel
+86-0571-86912261 +8613735419629
Email
sales@newcanbio.com